Autres langues FUSN PHAR

Actions

FUSN

CA36118A1003

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
21,42 ^USD	+0,09 %		+0,75 %	+122,89 %

16/04	FUSN PHAR : TD Cowen n'est plus positif	ZM
09/04	Fusion Pharmaceuticals Inc. présente les données intermédiaires d'efficacité et d'innocuité de l'essai clinique ouvert de phase 2 TATCIST évaluant le FPI-2265	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order	25/04
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order	25/04
Fusion Pharmaceuticals Inc. Presents Interim Efficacy and Safety Data from the Phase 2 TATCIST Open-Label Clinical Trial Evaluating FPI-2265	09/04
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024	09/04
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Fusion Pharmaceuticals Inc. - FUSN	27/03
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca	20/03
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/03
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates	20/03
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN	20/03
Sector Update: Health Care Stocks Rise Late Afternoon	19/03
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	19/03
Sector Update: Health Care	19/03
Top Midday Gainers	19/03
Top Stories at Midday: February US Housing Starts Rise; AstraZeneca to Acquire Fusion Pharmaceuticals; IFF to Sell Pharma Solutions Unit; Unilever to Spin Off Ice Cream Unit; MicroStrategy Completes Notes Offering; Super Micro Computer Files Shelf; Nvidia Unveils Latest GPU	19/03
AstraZeneca to buy Canadian cancer treatment developer Fusion Pharmaceuticals	19/03
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	19/03
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	19/03
Sector Update: Health Care	19/03
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday	19/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues FUSN PHAR

Actions

FUSN

CA36118A1003

Autres langues

Filtres